CTTI would like to welcome newest member Pulmonary Fibrosis Foundation. As a leading provider of education and support for the pulmonary fibrosis (PF) community, they represent one of many key stakeholders that CTTI engages to collaboratively improve the quality and efficiency of the clinical trials enterprise. Chief Executive Officer Daniel Rose, MD, will represent the Pulmonary Fibrosis Foundation on CTTI’s Steering Committee.

For more information about CTTI’s organizational structure, including the Steering Committee, CLICK HERE.